Age-related macular degeneration (AMD) is a leading cause of blindness in aged
individuals. Recent advances have highlighted the essential role of immune processes in …

In contrast to wet age-related macular degeneration (AMD), where loss of vision is typically
acute and treatment leads to a relatively rapid reduction in retinal fluid and subsequent …

Purpose To describe risk factors for geographic atrophy (GA) in the Comparison of Age-
related Macular Degeneration Treatments Trials (CATT). Design Cohort within a randomized …

There is an urgency to find new treatment strategies that could prevent or delay the onset or
progression of AMD. Different classes of lipids and lipoproteins metabolism genes have …

Age-related macular degeneration (AMD) is a multifactorial disease influenced by a
combination of environmental factors and genetic variants. Genomic studies have been …

PURPOSE: To present the current understanding of age-related macular degeneration
(AMD) pathogenesis, based on clinical evidence, epidemiologic data, histopathologic …

Pachychoroid neovasculopathy is a recently proposed clinical entity of choroidal
neovascularization (CNV). As it often masquerades as neovascular age-related macular …

Age-related macular degeneration (AMD) is a common cause of irreversible visual loss and
the disease burden is rising world-wide as the population ages. Both environmental and …

Purpose: Age-related macular degeneration (AMD) is a progressive disease with
multifactorial etiology. There is a need to identify clinical features that are harbingers of …

Adaptive optics (AO) is a technology used to improve the performance of optical systems by
reducing the effects of optical aberrations. The direct visualization of the photoreceptor cells …